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Abbreviations and Textual Footnotes  
AMP, antimicrobial peptide; CD, circular dichroism; CL, cardiolipin; Cs-1, compressibility 
modulus; CM, cytoplasmic membrane; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol); Emax, maximal levels of lysis; ΔGmix, Gibbs free energy of mixing; µH, hydrophobic 
moment; < H > mean hydrophobicity; Lys-PG, lysylated phosphatidylglycerol; Km, lipid affinity; 
Lys-DOPG, 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))]; MH5, Maximin H5; 
MIC,  minimum inhibitory concentration, PE, phosphatidylethanolamine; PG, 
phosphatidylglycerol; PMF, proton motive force; SUVs, Small unilamellar vesicles. 
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ABSTRACT Maximin H5 (MH5) is an amphibian antimicrobial peptide specifically targeting 
Staphylococcus aureus.  At pH 6, the peptide showed an increased ability to penetrate (∆П = 6.2 
mN m-1) and lyse (lysis = 48 %) S. aureus membrane mimics, which incorporated physiological 
levels of lysylated phosphatidylglycerol (Lys-PG, 60 %) as compared to pH 7 (∆П = 5.6 mN m-1 
and lysis = 40 % at pH 7) where levels of Lys-PG are lower (40 %). The peptide therefore appears 
to have optimal function at pH levels known to be optimal for the organism’s growth. MH5 killed 
S. aureus (minimum inhibitory concentration = 90 µM) via membranolytic mechanisms that 
involved the stabilization of α-helical structure (circa 45-50 %)  and which showed similarities to 
the ‘Carpet’ mechanism based on its ability to increase the rigidity (Cs-1 = 109.94 mN m-1) and 
thermodynamic stability (∆Gmix  = -3.0) of physiologically relevant S. aureus membrane mimics 
at pH 6. Based on theoretical analysis this mechanism may involve the use of a tilted peptide 
structure and efficacy was noted to vary inversely with the Lys-PG content of S. aureus membrane 
mimics for each pH studied (R2 circa 0.97), which led to the suggestion that under biologically 
relevant conditions, low pH helps mediate Lys-PG induced resistance in S. aureus to MH5 
antibacterial action. The peptide showed a lack of haemolytic activity (< 2  % haemolysis) and 
merits further investigation as a potential template for development as an anti-staphylococcal agent 
in medically and biotechnically relevant areas. 
 
 
 
 
Dennison et al. 2016. Biochemistry DOI: 10.1021/acs.biochem.6b00101 
 
 4 
Many amphibians secrete a wide range of antimicrobial peptides (AMPs) and other biologically 
active compounds to protect the skin from bacterial infection 1, 2 and these peptides have the 
potential for further commercial development, including roles as anti-infective, anticancer, anti-
viral and anti-diabetic agents 3-6.  For example, maximin H5 (MH5) is an anionic peptide that 
belongs to a family of AMPs identified in the skin secretions of the Chinese red belly toad, 
Bombina maxima 7 and in the brain of both B. maxima and other toads of the same genus 8. Several 
studies have shown MH5 to be effective against Staphylococcus aureus but it exhibited no activity 
against other Gram-positive bacteria, Gram-negative bacteria, fungi or enveloped viruses 7, 9. More 
recent work has suggested that that the peptide penetrates and disrupts membranes via the adoption 
of a tilted structure 10 and is rendered inactive against Escherichia coli via a novel resistance 
mechanism involving phosphatidylethanolamine (PE) binding 11. Essentially, charge-charge 
interactions together with a hydrogen bonding network between MH5 and PE in the cytoplasmic 
membrane (CM) of E. coli anchor the peptide to the bilayer surface thereby inhibiting its 
membranolytic action 11, 12.  
It is generally accepted that the interaction with the CM of target bacteria is an essential step in 
the antimicrobial action of AMPs 13-17 and interactions of this type have been investigated using a 
variety of model membranes 18-23.  These model membranes are usually formed from lipid mixtures 
with a head-group composition that reflects the molar ratio of the major lipids in the bacterial 
membrane, namely PE, phosphatidylglycerol (PG), Lys-PG and cardiolipin (CL). The CMs of 
Gram-negative bacteria are primarily composed of PE, such as that of E. coli, which typically 
contains approximately 80  % PE, 6  % PG and 12  % CL at neutral pH. In contrast, the CMs of 
Gram-positive bacteria are mainly composed of lipids derived from PG, exemplified by that of S. 
aureus, which typically contains circa 55  % PG, 40  % Lys-PG and 5  % CL at neutral pH 14, 15, 
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24. In general, anionic lipids constitute over 80  % of the total lipid found in the membranes of 
Gram-positive bacteria but less than 30  % of the total lipid present in those of Gram-negative 
bacteria 15. These varying levels of anionic lipid are thought to contribute to the differing bacterial 
specificities shown across AMPs 25, 26, which are generally cationic and target the cells of bacteria 
via electrostatic interactions with negatively charged components of the CM 13-15, 17.  
In contrast to anionic lipids of the CM, it is well established that the cationic lipid, Lys-PG, helps 
to provide S. aureus with a major mechanism of resistance to AMPs and also helps deal with 
environmental stresses that are optimal for the growth of the organism particularly under the low 
pH conditions 27-30. According to this mechanism of resistance, cationic AMPs activate a sensor 
histidine kinase (ApsS) of the ApsSR (GraSR) regulon, which leads to the up-regulated expression 
of the virulence factor mprF. The protein product of this gene, mprF, is a Lys-PG synthase that 
catalyses the transfer of lysine from lysyl-tRNA to the PG head-group and flipping of the resulting 
Lys-PG to the outer leaflet of the S. aureus CM 23, 31-34.  The presence of the lipid in the CM of S. 
aureus attenuates a number of membrane associated properties that inhibit the ability of cationic 
AMPs to bind and exert their membranolytic action against these membranes 27, 28, 31, 33-38. This 
effect in enhanced by low pH conditions, when the production of Lys-PG is upregulated and where 
levels of the Lys-PG as high as 80  % of total membrane lipid have been reported for the organism 
29, 39-42. 
In general, the role of Lys-PG in mediating resistance to cationic AMPs in S. aureus has been 
well characterised 27, 31, 33, 35, 43-45 but there is limited information on what if any role this 
mechanism of resistance has against anionic AMPs 46-48. Accordingly, here, we have characterised 
the action of MH5 against S. aureus and investigated the role of Lys-PG its activity. Our results 
show that MH5 adopts lipid interactive α-helical structure and kills S. aureus via a membranolytic 
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mode of action that is similar to the ‘Carpet mechanism’ and furthermore, activity is enhanced by 
low pH. However, our results also suggest that the action of MH5 is attenuated by the presence of 
Lys-PG in the CM of the organism, which inhibits insertion by the peptide through membrane 
stabilization and lipid packing effects.  
 
EXPERIMENTAL PROCEDURES 
Materials - The peptide homologue of maximin H5, MH5 (ILGPVLGLVSDTLDDVLGIL-
NH2) to purity greater than 95  % was purchased from Pepceuticals (Leicestershire, UK).   Solvents 
and phospholipids including: cardiolipin (CL); 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol) (DOPG); and 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] (Lys-
DOPG) were purchased from Avanti Polar Lipids (Alabaster, AL) and were used without further 
purification.  Solvents were obtained from VWR (HPLC grade) and unless otherwise stated, all 
other regents were purchased from SIGMA-ALDRICH (UK). 
 
The antibacterial properties of MH5 - Cultures of S. aureus, strain UL12, which had been freeze-
dried in 20  % (v/v) glycerol and stored at −80 ºC, were used to inoculate 10 ml aliquots of sterile 
Nutrient broth and incubated at 37 °C until the exponential phase (OD = 0.6; λ = 600 nm) was 
reached.  Using a bench top centrifuge, these cell suspensions were centrifuged at 15,000 × g at 4 
°C for 10 minutes.  The resulting pellet was washed three times in 25  % Ringer’s solution and 
then resuspended in 500 μl of the same medium. Aliquots (10µl) of these cell suspensions were 
then used to inoculate samples of MH5, which were solubilised in 25  % strength Ringer’s solution 
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(0 µM to 1000 µM), and incubated at 37 °C overnight. After incubation, each bacterial culture was 
streaked on to a nutrient agar plated and incubated at 37 °C for 12 h. 
                                        
Total lipid extracts from cells of S. aureus  - Lipid extracts from membranes of S. aureus were 
prepared using a protocol based on the technique of Bligh and Dyer 49. Essentially, bacterial 
cultures were grown, washed and resuspended in 500 μl of 25  % strength Ringer’s solution, all as 
described above. These cell suspensions were then vortexed with 1.5 ml of chloroform: methanol 
(2:1) for 5 minutes, water (500 μl) was then added and the whole vortexed for 5 minutes before 
being centrifuged at low speed (660 × g, 5 min) to produce two phases.  The lower organic layer 
was concentrated by removing the solvent with N2 (g).   
 
Theoretical analyses of MH5 – The potential of MH5 to form a membrane interactive α-helix 
was determined using the hydrophobic moment methodology of Eisenberg et al., 50, 51. According 
to this methodology, the hydrophobicity of successive amino acids in a protein sequence are treated 
as vectors and summed in two dimensions, assuming an amino acid side chain periodicity of 100°. 
This summation leads to the mean hydrophobic moment, < µH >, which provides a measure of α-
helix amphiphilicity. Using the normalised consensus hydrophobicity scale of Eisenberg et al., 52 
and a moving window of 11 residues, the window in the sequence of MH5 with the highest value 
of < µH > was computed along with its mean hydrophobicity, < H >. Using these values of < µH > 
and < H > as coordinates, a data point representing MH5 was plotted on the hydrophobic moment 
plot diagram of Eisenberg et al. 50, as modified by Harris et al. 53, to identify candidate tilted α-
helix forming segments. Graphical representation of MH5 as a two-dimensional axial projection 
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taken perpendicular to the helical long axis and assuming an amino acid periodicity of 100° was 
undertaken according to the methodology of Schiffer and Edmundson 54.    
 
The structural determination of MH5- Small unilamellar vesicle (SUVs) were prepared from 
either lipid extracts of S. aureus membranes or CL, DOPG, Lys-DOPG, or DOPG:CL:Lys-DOPG 
in the molar ratio 55:5:X where X = 0 , 20, 40, 60, 80 or 100. These single lipids and lipid mixtures 
were dissolved separately in chloroform and dried under N2 (g) before being placed under vacuum 
for 4 hours.  The resulting lipid films were rehydrated using 1 × phosphate buffered saline (PBS) 
at pH values of either pH 6, pH 7 or pH 8, sonicated for an hour or until the solution was no longer 
turbid, and then subjected to 5 cycles of freeze-thawing. MH5 (0.1 mg ml-1) was then solubilised 
in these SUVs to give a peptide to lipid ratio of 1:100 and these samples used for circular dichroism 
(CD) analysis.  These analyses were performed using a J-815 spectropolarimeter (Jasco, UK) at 
20 °C, all as previously described 55.  Far-UV CD spectra were collated, for MH5 in the presence 
and absence of lipid.  Four scans per sample were performed using a 10 mm path-length cell, over 
a wavelength range 260 to 180 nm at 0.5 nm intervals using a band width of 1 nm and a scan speed 
50 nm min-1.  For all spectra acquired, the baseline acquired in the absence of peptide was 
subtracted 56.  The percentage α-helical content was estimated using the CDSSTR method (protein 
reference set 3) from the DichroWeb server 57-59. These experiments were repeated in quintuplicate 
and the percentage α- helicity was averaged.  
Langmuir trough analysis of MH5 - All monolayer experiments were performed at room 
temperature (20 °C) using a Teflon 601M Langmuir Blodgett trough (Biolin Scientific KSV 
NIMA, UK) equipped with moveable barriers and the surface pressure measured using a Wilhelmy 
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plate made of Whatman’s CH1 filter paper, all as previously described 11. In all experiments, the 
trough subphase consisted of PBS prepared with Milli-Q-water (resistivity ≈ 18 MΩ cm) and was 
at pH values of either 6, 7 or 8.  
The surface activity of MH5 - To determine the surface activity of MH5, the peptide was injected 
into the Langmuir trough PBS subphase at pH values of either pH 6, pH 7 or pH 8 via an injection 
port using a Hamilton syringe to give final MH5 concentrations ranging between 1.0 and 18 µM.  
After injection, the maximal surface pressures induced by the peptide were recorded as a function 
of the final MH5 concentration in the subphase. Each experiment was repeated in quintuplicate 
and the mean taken.  
To determine the interfacial orientation of MH5, chloroformic solutions of the peptide (1.5 × 
1015 molecules) were spread onto the Langmuir trough PBS subphase at pH values of either pH 6, 
pH 7 or pH 8. In each case, the peptide film was allowed to stabilize for 10 minutes and the trough 
barriers compressed at a constant speed of 0.33 nm2 min-1 until the collapse pressure was achieved. 
Each experiment was repeated in quintuplicate and the mean value taken. 
 
The interaction of MH5 with lipid monolayers - Monolayers were formed by spreading the 
chloroformic solutions of lipid onto the Langmuir trough PBS subphase at pH values of either pH 
6, pH 7 or pH 8. These chloroformic solutions contained either lipid extracts of membranes of S. 
aureus or CL, DOPG, Lys-DOPG or DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X = 
0 , 20, 40, 60, 80 or 100.  The trough barriers were closed at a rate of 5 cm2 min-1 until a starting 
pressure of 30 mN m-1 was achieved, which is generally taken as that of naturally occurring 
membranes 60.  Monolayers were allowed to equilibrate for 30 minutes and using a Hamilton 
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syringe, MH5 was injected into the trough subphase without disruption of the monolayer to give a 
final peptide concentration of 2.0 µM. The subphase was continuously mixed with a magnetic 
stirrer at 5 rpm, each experiment repeated in quintuplicate and the mean value taken. 
For compression isotherm analysis, monolayers were formed by spreading chloroformic 
solutions of lipid (2.6 x 1015 molecules) onto the Langmuir trough PBS subphase at pH values of 
either pH 6, pH 7 or pH 8. These chloroformic solutions contained either CL, DOPG, Lys-DOPG 
or DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X = 0 , 20, 40, 60, 80 or 100. These lipid 
monolayers were allowed to settle for 30 min and the trough barriers were closed at a rate of 0.22 
nm2 min-1 until the monolayer collapse pressure was achieved.  These experiments were then 
repeated with MH5 in the trough PBS subphase after introduction via an injection port using a 
Hamilton syringe to give a final peptide concentration of 8 µM.  The compressibility modulus (Cs-
1) at each of the experimental mixing ratios was then calculated by applying the following equation 
61.  
                                                                  





−=−
A
ACs δ
δπ1
    (1) 
where A is the area per molecule at a given surface pressure (π).  
Using these isotherms, the thermodynamic stability of monolayers was then investigated by 
applying the Gibbs equation: 
                              πdAXAXAGmix )([ 221112 +−=∆ ∫      (2) 
where A1,2, ...n is the molecular area occupied by the mixed monolayer, A1, A2 …An are the area per 
molecule in the pure monolayers of component 1, 2,…n, X1, X2…Xn are the molar fractions of the 
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components and π is the surface pressure.  Numerical data were calculated from the compression 
isotherms according to the mathematical method of Simpson 62.   
 
The lytic activity of MH5 - To determine the lytic ability of MH5, chloroformic solutions were 
prepared from either lipid extracts of S. aureus membranes, or DOPG:CL:Lys-DOPG in the molar 
ratio 55:5:X where X = 0 , 20, 40, 60, 80 or 100. These various lipid solutions were taken and the 
chloroform evaporated off under a stream of nitrogen before further drying under vacuum for 1 
hour to form a thin film.  The lipid film was then hydrated with 1 ml of 5.0 mM HEPES containing 
70 mM calcein at either pH 6, 7 or 8.  The resulting suspension was vortexed for 5 minutes, 
sonicated for 30 minutes and then subjected to 3 cycles of freeze-thawing.  Liposomes were 
extruded 11 times through a 0.1 µm polycarbonate filter using an Avanti polar lipids min-extruder 
apparatus.  Calcein entrapped vesicles were separated from free calcein by gel filtration using a 
Sephadex G75 column (SIGMA-ALDRICH (UK)), which was rehydrated overnight in 20 mM 
HEPES, 150 mM NaCl and 1.0 mM EDTA at either pH 6, 7 or 8. The column was eluted with 5 
mM HEPES either pH 6, 7 or 8. 
The calcein release assay was performed by combining 2 ml of 20 mM HEPES, 150 mM NaCl 
and 1.0 mM EDTA with 20 µl calcein vesicles at either pH 6, 7 or 8.  MH5 was then added to 
these mixtures to give final peptide concentrations ranging from 0 to 1 mM and the whole 
incubated for 2 hours at room temperature (20 °C). The fluorescence intensities of calcein were 
measured using an FP-6500 spectrofluorometer (Jasco, UK), with an excitation wavelength of 490 
nm and an emission wavelength of 520 nm.  To measure maximum fluorescence, 20 µl of Triton 
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×100 was used to dissolve the vesicles. Each experiment was repeated in quintuplicate and the 
mean percentage of dye leakage was then calculated taken. 
 
The haemolytic properties of MH5 - The activity of the peptide against ovine erythrocytes was 
determined as previously described 63. Essentially, these erythrocytes (3 ml) were taken and 
washed three times with PBS (35 mM phosphate buffered saline, 0.15 M NaCl, pH 7.4) by 
centrifugation (1,200 × g, 5 min) until the supernatant was clear. Washed erythrocytes were then 
resuspended in PBS to a final volume of 20 ml. Solutions (10 μl) containing MH5 at appropriate 
concentrations were added to  suspension of washed erythrocytes (190 μl) and were incubated for 
1 h at 37 °C. The samples were then centrifuged (12,000 × g, 5 min). The release of haemoglobin 
was monitored by diluting 100 μl of supernatant with 900 μl PBS and absorbance measured at 576 
nm. For negative and positive controls, PBS buffer [APBS] and 0.1  % Triton X-100 [ATriton] were 
used. The percentage haemolysis was calculated according to the following equation:  
Percentage haemolysis = [APeptide] − [APBS] / [ATriton] − [APBS]   × 100. 
In all cases, values of the  % haemolysis were determined in quadruplicate and the mean value 
derived. 
 
RESULTS 
The antimicrobial properties of MH5 – The peptide belongs to a suite of AMPs that are known 
to have activity against a variety of prokaryotic microorganisms 7, 8 and during the course of this 
investigation the peptide was tested against strains of S. aureus using a standard antimicrobial 
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assay. After 12 hours of incubation with the organism, MH5 exhibited activity against S. aureus 
with a minimum inhibitory concentration (MIC) of 90 μM. 
 
Theoretical analyses of MH5 - The sequence of MH5 was analysed according to hydrophobic 
moment plot methodology and was found to exhibit an amphiphilicity of 0.44, measured as < μH 
>, and a hydrophobicity of 0.29, quantified as < H > 64, 65. Values of < μH > with this order of 
magnitude have been reported for other anionic AMPs and are generally indicative of the potential 
to form α-helical structure in an anisotropic environment with activity at an aqueous or membrane 
interface 66. Using the values of < μH > and < H > determined for MH5 as coordinates, this α-helix 
was plotted on the extended hydrophobic moment plot diagram of Harris et al. 53 and the location 
of the data point indicated the potential to form a tilted peptide with similar parameters to HA2, a 
viral fusion peptide and known tilted peptide (Figure 1A). Tilted peptides are a class of amphiphilic 
α-helices that also possess a hydrophobicity gradient along the α-helical long axis.  This structural 
feature causes the α-helix to penetrate membranes at a shallow angle of between 20° and 80°, 
thereby promoting a range of membrane destabilizing effects including the disturbance of lipid 
organisation and the compromise of bilayer integrity 14, 67-71. To characterise the potential for tilted 
peptide formation, amphiphilic profiling of MH5 was undertaken, which essentially visualises 
potential hydrophobicity gradients via plots of - < µH >  along a peptide’s sequence 72. This analysis 
revealed that MH5 possessed a strong hydrophobicity gradient, which decreased in the direction 
of the N terminus to the C terminus and extended over most of the peptide’s primary structure 
(Figure 1B). MH5 was then represented as a two-dimensional axial projection, assuming a residue 
periodicity of 100° 54 and this α-helix showed well defined amphiphilicity (Figure 1C). Consistent 
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with the ability to form a tilted peptide, the MH5 α-helix possessed a wide apolar face, 
predominantly formed from strongly hydrophobic residues such as leucine, isoleucine and valine 
(Figure 1C). The α-helix possessed a narrower polar face with multiple glycine residues and a 
triplet of aspartic acid residues, which rendered this α-helical face strongly anionic. These residues, 
D11, D14 and D15, essentially define the polar face of the MH5 α-helix and are centrally clustered 
in relation to the long axis of this α-helix (Figure 1C). The M5 α-helix showed structural 
similarities to that of HA2, which also includes a wide apolar face formed from strongly 
hydrophobic residues and a narrower anionic polar face with multiple glycine residues (Figure 
1C). It is believed that the lack of charge and conformational flexibility provided by glycine 
residues plays an important role in facilitating the oblique membrane insertion of tilted peptides 14, 
67-71.  
 
The surface activity of MH5 - Amphiphilic AMPs are generally highly surface active 18, 22 and 
here, MH5 was investigated for such activity at an air / buffer interface (Figure 2A). It was found 
that at pH 6, pH 7 and pH 8, the surface pressure changes induced by the peptide increased rapidly 
up to concentrations of 2 µM.  Above this concentration, surface pressure became independent of 
MH5 levels, indicating that the air / buffer interface was saturated with molecules of the peptide.  
These surface pressure changes were maximal at pH 6 with a value of 28.0 mN m-1 and dropped 
to 26.0 mN m-1 at pH 8, indicating that MH5 possesses generally high surface activity, which was 
enhanced by acid conditions (Figure 2A). Saturation surface pressures of this order are generally 
characteristic of peptides with membrane interactive structure, such as AMPs 73, 74.     
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The orientation of MH5 at an air / buffer interface was investigated using compression isotherms 
and it was found that at pH 6, pH 7 and pH 8, these isotherms have a generally sigmoidal shape 
indicating that the peptide forms stable monolayers (Figure 2B) 18, 22. Under compression, these 
monolayers showed collapse surface pressures that indicated the presence of well-ordered peptide 
films with a maximal value of 26.8 mN m-1 at pH 6, which dropped to 24.1 mN m-1 at pH 8 75. The 
corresponding surface areas per molecule of MH5 ranged between 1.9 nm2  and 1.6 nm2, which is 
comparable to that reported for other AMPs, such as aurein 2.5 (Figure 2B) 76, and would be 
expected if MH5 were in an α-helical conformation, orientated perpendicular to the interface 77.   
The extrapolated area at п = 0 mN m-1 for these isotherms provides a measure of the mean 
monolayer surface area per MH5 molecule and it was found that this area is maximal at pH 6 with 
a value 4.5 nm2 which drops to  4.1 nm2 at pH 8 (Figure 2B). Mean molecular areas of this order 
are comparable to those reported for other AMPs 78 and would be expected for MH5 in an α-helical 
conformation that was orientated parallel to the interface 79. In combination, these results imply 
that under all the pH conditions studied here, the amphiphilic characteristics possessed by MH5 in 
an α-helical conformation are able to influence the orientation of the peptide in the anisotropic 
environment provided by an interface. 
 
Secondary structure of MH5 in the presence of lipid mimics of S. aureus membranes - The 
conformational behaviour of MH5 was studied and at pH 6, pH 7 and pH 8, and in aqueous solution 
the peptide was predominantly formed from β-strands, β-turns and unordered structure, consistent 
with previous reports 11. However, in the presence of SUVs formed from lipid extracts of S. aureus 
membranes, at pH 6, pH 7 and pH 8, CD spectra showed minima at 221 - 222 and 209 – 210 nm 
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(Figure 3), which is indicative of α-helical structure in MH5 55.  Analysis of these CD spectra 
revealed that the levels of α-helicity were around 48 % at pH 8, but increased to 58 % as pH was 
decreased to pH 6, showing clearly that MH5 is able to form an α-helical structure in the presence 
of an asymmetric interface that is enhanced by low pH (Table 1).  
To form lipid mimics of S. aureus membranes with known compositions, SUVs were 
constructed from DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X =  0 , 20, 40, 60, 80 or 
100, and the conformational behaviour of MH5 in the presence of these lipid bodies investigated 
(Figure 4). For a given value of X, it was found that the peptide adopted α-helical structure in a 
pH dependent manner that closely mimicked that observed for MH5 in the case of SUVs formed 
from lipid extracts of S. aureus membranes (Table 1). These observations confirmed that synthetic 
lipid mixes were able to simulate the naturally occurring membranes of S. aureus, which were then 
used to investigate the influence of Lys-DOPG levels in these membranes on the conformational 
behaviour of MH5 at pH 6, pH 7 and pH 8. For each pH studied, it was found that MH5 was 
predominantly α-helical and possessed similar levels of this structure for all values of X (Figure 
4). However, for a given level of X, a statistically significant difference in levels of MH5 α-helicity 
was observed as pH was varied (Figure 4B), decreasing from circa 50 % at pH 6 to circa 40 % at 
pH 8 [F = 98.376; p = 0.001]. In relation to physiological levels of the lipid in membranes of S. 
aureus, which are typically X = 60 at pH 6, and X = 40 at pH 7 29, 39-42, MH5 possessed levels of 
α-helicity of circa 45 % at pH 7 (X = 40), which increased by around 5 % at pH 6 (X = 60) (Figure 
4B).  These results indicate that the levels of α-helicity possessed by MH5 were enhanced by low 
pH conditions with varying Lys-DOPG having limited influence on α-helicity. 
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The interaction of MH5 with lipid mimics of S. aureus membranes - The levels of amphiphilicity 
predicted for MH5 are consistent with membrane interactive potential (Figure 1) and lipid 
monolayers formed from lipid extracts of S. aureus membranes were used to investigate this 
potential at pH 6, pH 7 and pH 8 (Figure 5A). At each pH studied, the peptide rapidly induced 
pressure changes in these monolayers until they became saturated with MH5. At pH 7 and pH 8, 
MH5 partitioned into these monolayers, inducing maximal surface pressure changes of circa 4.0 
mN m-1 to 3.5 mN m-1 over 400 seconds. However, at pH 6, MH5 induced maximal surface 
pressures in monolayers of the order of 8.0 mN m-1 over 120 seconds, showing clearly that the 
ability of the peptide to partition into lipid mimics of S. aureus membranes monolayers was 
enhanced by low pH conditions (Figure 5A). 
Monolayers formed from lipid mimics of S. aureus membranes with known compositions were 
constructed from DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X =  0 , 20, 40, 60, 80 or 
100, and were used to investigate the influence of varying Lys-DOPG levels on the membrane 
interactions of MH5 at pH 6, pH 7 and pH 8 (Figure 5B). For each pH studied, it was found that 
the maximal pressure change induced by the peptide showed a strong negative correlation with X, 
which was R2 = 0.95 at pH 6, 0.97 at pH 7 and 0.99 at pH 8. This inverse correlation shows clearly 
that the presence of Lys-DOPG in lipid mimics of S. aureus membranes is able to inhibit the ability 
of MH5 to insert into these membranes. However, for a given level of X, the ability of MH5 to 
partition into membranes was observed to vary with pH, for example, at X = 20, the pressure 
changes induced by the peptide decreased from 7.4 mN m-1 at pH 6 to 6.15 mN m-1 at pH 8 (Figure 
5B), In relation to physiological levels of Lys-DOPG in membranes of S. aureus, MH5 induced 
maximal surface pressure changes of 5.6 mN m-1 at pH 7 (X = 40), which increased to 6.2 mN m-
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1 at pH 6 (X = 60) (Figure 5B). These results clearly indicate that the ability of the peptide to 
partition into S. aureus membranes is enhanced by low pH conditions. 
 
Thermodynamic analysis of MH5 interactions with lipid mimics of S. aureus membranes - 
Monolayers were constructed from DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X =  0, 
20, 40, 60 or 80, and were compressed in the presence and absence of MH5 to produce isotherms 
at pH 6, pH 7 and pH 8 (Figure 6). For each of these experimental systems, the isotherms produced 
were then used to derive values for Cs-1, the compressibility modulus, at 20 mN m-1 (Table 2). It 
was found that at each pH studied, in the absence of MH5, increasing X led to elevations in the Cs-
1 values of these monolayers. This trend indicated that increasing levels of Lys-DOPG decreased 
the area per lipid molecule in these monolayers and hence promoted increasingly denser lipid 
packing. Similar trends were observed for corresponding monolayers in the presence of MH5 
except that higher Cs-1 values were generated, indicating that the presence of the peptide promoted 
relatively denser lipid packing as compared to that in the absence of MH5 (Table 2). For a given 
level of X, it was found that decreasing pH also led to increases in the Cs-1 values of monolayers 
and hence relatively denser lipid packing. For corresponding monolayers in the presence of MH5, 
similar trends were observed, except that higher Cs-1 values were generated, indicating that the 
presence of the peptide led to relatively denser lipid packing as compared to that in the absence of 
MH5 (Table 2). In relation to physiological levels of Lys-PG in membranes of S. aureus, in the 
absence of MH5, the Cs-1 of monolayers were 36.1 mN m-1 (X = 40) at pH 7 and 42.9 mN m-1 (X 
= 60) at pH 6, indicating that the latter monolayers were more rigid and possessed relatively denser 
lipid packing than the former (Table 2). The presence of MH5 led to increases in the Cs-1 of both 
these monolayers, which were 43.54 mN m-1 (X = 40) at pH 7 and 109.9 at mN m-1 (X = 60). 
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These latter results indicate that the presence of MH5 increased the rigidity and lipid packing 
density of both monolayers, which is consistent with the peptide partitioning into these 
membranes. Moreover, this effect was of the order of ten-fold greater at pH 6 (change in Cs-1 of 
63.0) as compared to pH 7 (change in Cs-1 of 7.5), indicating that the ability of MH5 to partition 
into membranes of S. aureus is strongly enhanced by low pH conditions (Table 2). 
The compression isotherms of Figure 6 were also used to derive values for the Gibbs free energy 
of mixing, ∆Gmix, at 20 mN m-1 for monolayers formed from DOPG:CL:Lys-DOPG in the molar 
ratio 55:5:X where X =  0 , 20, 40, 60 or 80 at pH 6, pH 7 and pH 8 (Figure 7). A pH dependent 
threshold level of Lys-DOPG was observed at which these monolayers become 
thermodynamically stable, rising from X = 0 at pH 7 to X = 20 at pH 8 (Figure 7). At each pH 
studied, in the absence of MH5, increasing X led to elevations in the ∆Gmix values of these 
monolayers. This trend indicated that as levels of Lys-DOPG were increased, the thermodynamic 
stability of these monolayers became progressively higher. Similar trends were observed for 
corresponding monolayers in the presence of MH5 except that higher ∆Gmix values were generated, 
indicating that the presence of the peptide promoted relatively higher levels of thermodynamic 
stability in these monolayers, as compared to those formed in the absence of MH5 (Figure 7). For 
a given level of X, it was found that decreasing pH also led to increases in the ∆Gmix values of 
monolayers and hence relatively higher levels of thermodynamic stability. For corresponding 
monolayers in the presence of MH5, similar trends were observed except that higher ∆Gmix values 
were generated, indicating that the presence of the peptide promoted relatively higher levels of 
thermodynamic stability in these monolayers when compared to those formed in the absence of 
MH5 (Figure 7). In relation to physiological levels of Lys-DOPG in membranes of S. aureus, in 
the absence of MH5, the ∆Gmix of monolayers were -2.0 (X = 40) at pH 7 and -5.0 (X = 60) at pH 
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6, indicating that the latter monolayers were thermodynamically more stable than the former 
monolayers (Figure 7). The presence of MH5 led to increases in the ∆Gmix values of both these 
monolayers, which were -3.0 (X = 40) at pH 7 and -8.0 (X = 60). These latter results indicate that 
the presence of MH5 increased the thermodynamic stability of both monolayers and that this effect 
was in the order of three-times greater at pH 6 (change in ∆Gmix of -1) when compared to pH 7 
(change in ∆Gmix of -3). These results show that the ability of MH5 to increase the thermodynamic 
stability of membranes of S. aureus is strongly enhanced by low pH conditions (Figure 7). 
 
The ability of MH5 to permeabilise lipid mimics of S. aureus membranes - Calcein entrapped in 
vesicles, which were constructed from either, lipid extracts of S. aureus membranes, or 
DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where X =  0, 20, 40, 60 and 80 or 100, were used 
to investigate the lytic ability of MH5 at pH 6, pH 7 and pH 8. In the case of vesicles formed from 
lipid extracts of S. aureus membranes, it was found that at each pH studied, the peptide induced 
the release of calcein from these vesicles with the level of the dye released increasing as the 
concentration of MH5 became progressively higher, showing that MH5 was generally lytic to these 
membranes. At MH5 concentrations of circa 500 μM, the release of calcein from these vesicles 
became independent of peptide concentration, indicating that membranes were saturated with 
MH5 and levels of dye release were maximal, ranging from 40.3 % at pH 8 to 72.6 % at pH 6 
(Figure 8). It was also found that the levels of lysis induced by the peptide were enhanced by 
decreasing pH, for example, at the MIC of MH5 for S. aureus (90 µM), levels of dye release 
induced by the peptide were circa 30 % at pH 8 but rose to 57 % at pH 6 (Figure 8).  
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To gain further insight into the membranolytic ability of MH5, vesicles were constructed from 
DOPG:CL:Lys-DOPG, and it was found that at each pH studied, the peptide induced the release 
of calcein from these vesicles for all values of X (Figure 9). In the case of both Figure 8 and Figure 
9, calcein release from vesicles by MH5 showed kinetics that were similar to the Michaelis-
Menten-type kinetics of lytic AMPs that utilise ‘Carpet’-like mechanisms in their antimicrobial 
action 74, 76, 80. For membranes formed from DOPG:CL:Lys-DOPG, the kinetics of MH5 lytic 
action were characterized by Km values, which provides an inverse measure of the lipid affinity of 
the peptide and ranged from 38 to 60 µM at pH 6, 42 to 65 µM at pH 7 and 45 to 68 µM  at pH 8. 
These kinetics were also characterized by Emax values, which represent the lytic efficiency of MH5 
and varied between 58 and 73  % lysis at pH 6; 45 and 62  % lysis at pH 7; and 40 and 58  % lysis 
at pH 8 (Figure 9). For the data in Figure 9, a comparison between pH 6 (Figure 6A) and pH 8 
(Figure 6C) showed that there was a significant difference between Km values (p = 0.033) and Emax 
values (p = 0.002). These data showed that maximal levels of lysis and the lipid affinity of the 
peptide for a given Lys-DOPG concentration were highest at pH 6 and generally decreased with 
increasing pH. For example, at X = 20 and an MH5 concentration of 250 µM, the maximal levels 
of calcein released by the peptide, Emax, increased from 58.0  % at pH 8 to 73.0  % at pH 6 (Figures 
9A, and 9C).  For the same lytic curve, Km decreased from 45 μM at pH 8 to 38 μM at pH 6, 
indicating an increase in the lipid affinity of the peptide (Figures 9A and 9C). The data in Figure 
9 also showed that at each pH studied, for a given peptide concentration, the levels of calcein 
release induced by MH5 varied inversely with X. This inverse correlation shows clearly that the 
presence of Lys-DOPG in lipid mimics of S. aureus membranes is able to inhibit the ability of 
MH5 to induce the lysis of these membranes (Figure 9). To investigate the membranolytic ability 
of MH5 under biologically relevant conditions, Figures 9A, 9B and 9C were used to generate 
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Figure 9D. This figure shows the  % lysis induced by MH5 at its MIC of 90 µM in vesicles formed 
DOPG:CL:Lys-DOPG in the molar ratio 55:5:X  with varying X at pH 6 (black crosses), pH 7 
(dark grey crosses) and pH 8 (light grey crosses). At the physiological levels of Lys-PG found in 
membranes of S. aureus, this concentration of MH5 induced levels of lysis of circa 40  % (X = 40) 
at pH 7, which rose to 48  % (X = 60) at pH 6, indicating that the ability of the peptide to lyse 
membranes of the organism is strongly enhanced by the low pH conditions that are optimal for its 
growth (Figure 9D).  
The haemolytic properties of MH5 - The peptide was assayed for activity against ovine 
erythrocytes at pH 6, pH 7 and pH 8 (Figure 10). In each case, the peptide showed similar kinetics 
with haemolysis increasing up to MH5 concentrations of circa 1000 μM and then becoming 
independent of peptide concentration. Levels of haemolysis were generally very low (> 2  %) and 
increased with decreasing pH, for example, at the MIC of MH5 (90 μM), the  % haemolysis 
induced by the peptide varied between 1.6  % at pH 6 and 1.2  % at pH 8 (Figure 10). These levels 
of haemolysis are comparable to those recently reported for other anionic amphibian AMPs 81. 
 
DISCUSSION 
The ability of S. aureus to proliferate under acidic conditions enables the organism to colonize 
human epidermal surfaces such as the skin and the anterior nares of the nasal cavity 82, 83. Strains 
of the organism, including those with methicillin resistance, are responsible for the vast majority 
of bacterial skin infections in humans 84, 85 and have developed multiple mechanisms to evade 
antibiotics 86, 87, the adaptive immune response and the action of endogenous AMPs 43, 88. 
Currently, therefore, there is a clear need for new drugs with novel mechanisms of action against 
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strains of S. aureus 89 and based on its apparent specificity for the organism 7, 9, here, we have 
investigated the potential of MH5 to meet this need.   
Bacterial membranes are complex and dynamic structures and it is generally accepted that lipid 
monolayer and vesicle systems provide good mimics of these membranes under in vivo conditions. 
These lipid systems have the advantage that they adequately reflect the structural characteristics 
of the membranes they mimic whilst possessing sufficient simplicity to permit systematic analysis 
of changes in their properties in response to interaction with AMPs 18-23, 90, 91. Using these model 
membrane systems, our data would suggest that the protective effects afforded S. aureus against 
cationic AMPs by the physiological levels of Lys-PG  found in membranes of the organism are 
enhanced by low pH, as recently reported for other bacteria 92. Here, under acid conditions, the 
physiological levels of Lys-PG found in membranes of S. aureus (60  %) promoted a ten-fold 
increase in the lipid packing density and a three-fold increase in the thermodynamic stability of 
lipid mimics of these membranes as compared to lipid mimics containing the levels of LyslyPG 
present in membranes of the organism at pH 7 (40  %) (Table 2, Figure 7). It has recently been 
shown that increasing levels of Lys-PG and other lysylated phospholipids promote the 
rigidification and stabilisation of bacterial membranes through the reduction of electrostatic 
repulsion between anionic lipid head-groups, thereby inhibiting the ability of AMPs to penetrate 
these membranes 35, 36.  Moreover, it is generally accepted that a contribution to the protective 
mechanism provided by Lys-PG derives from a ‘charge effect’ whereby the positively charged 
head-group carried by the lipid is able to reduce the net negative charge of host bacterial 
membranes thus inhibiting the binding of cationic AMPs to these membranes 27, 28, 31, 33-38. It 
therefore seems likely that the contribution made by ‘charge effects’ to this protective mechanism 
is further enhanced by low pH given that the Lys-PG head-group is predominantly cationic under 
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acid conditions but becomes more zwitterionic in character as pH is increased 29, 93. Taken in 
combination, these data clearly suggest that the ability of Lys-PG to attenuate the surface charge 
and lipid packing properties of S. aureus membranes provides the organism with resistance to the 
action of MH5, which is enhanced under the low pH conditions that are optimal for the growth of 
the organism.   
A fundamental requirement in the antimicrobial action of AMPs is the ability to accommodate 
both the polar and apolar compartments of target microbial cells 14, 94-97. Consistent with this 
ability, MH5 was predicted to adopt amphiphilic α-helical structure in an anisotropic environment 
(Figure 1) and has the potential to form a tilted structure as seen for other membrane interactive α-
helices 98. Supporting this prediction, the peptide appeared to adopt such secondary structure at an 
aqueous interface across the pH range, pH 6 to pH 8, and exhibit high levels of surface activity 
(Figure 2A). Across the same pH range, MH5 also showed a strong ability to adopt amphiphilic 
α-helical structure in the presence of model S. aureus membranes (Figures 3 and 4) and to partition 
into these membranes (Figure 5). These observations suggest quite clearly that the activity of MH5 
against S. aureus may involve membranolytic action, which is the predominant antimicrobial 
mechanism employed by AMPs 14, 96. Confirming this suggestion, the peptide exhibited pH 
dependent lytic action against model S. aureus membranes that appeared to be contingent upon 
the properties of both the peptide itself and these target membranes (Figures 8 and 9). In relation 
to MH5, the highest levels of this membranolytic activity were observed at low pH (circa 80  % 
to 90  %, Figure 9A; Figures 9B and 9C) when the levels of amphiphilic α-helical structure adopted 
by the peptide were also at their highest (circa 50  % to 60  %, Table 1; Figures 3 and 4). This 
conformational behaviour would maximise the area of the hydrophilic and hydrophobic sites on 
the surface of MH5 and thereby its ability to penetrate and perturb S. aureus membranes. It is well 
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established that similar structural arrangements play a key role in facilitating the bacteriolytic 
action of many other α-helical AMPs 14. In combination, these observations strongly suggest that 
the low pH mediated stabilisation of amphiphilic α-helical structure plays a major role in the 
membranolytic activity of MH5 towards S. aureus.  
S. aureus appears to have a number of mechanisms that protect it from the action of cationic 
AMPs that involve reduction in the negative surface charge of its membrane and outer layers 99, 
100. For example, a recent study suggested that low pH mediated a decrease in the anionicity of 
teichoic acids in the organism’s peptidoglycan layer, thereby inhibiting the activity of a number of 
positively charged AMPs 101. It may therefore be predicted that such protective mechanisms may 
have a contrary effect in the case of anionic AMPs and enhance the ability of these peptides to 
target and kill S. aureus. However, our data showed that the membranolytic action of MH5 varied 
inversely with the Lys-PG content of S. aureus membranes at any given pH in the range, pH 6 to 
pH 8, suggesting that Lys-PG has provided a protective effect (Figure 5B). This effect is the 
opposite to what might be expected for MH5, which is overall anionic, given the ability of Lys-
PG to protect S. aureus from the action of cationic AMPs. In combination, these observations may 
imply that the membranolytic form of MH5 effectively acts as a cationic AMP, which would 
appear to be the first report of such behaviour for an amphibian peptide although it has been 
described for anionic AMPs from plants 94, 95. Functioning as a cationic AMP could involve the 
amidated residues at the termini of the MH5 primary structure, which are positively charged across 
the pH range studied here. Moreover, these amidated residues are relatively more accessible to 
external molecules than the anionic residues possessed by the peptide, which are more centrally 
located in relation to the longitudinal axis of α-helical MH5 11, 12, 102. It also seems likely that the 
amide moiety at the C-terminus of MH5 helps promote stabilisation of the peptide’s α-helical 
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secondary structure. It is well established that C-terminal amidation provides an extra hydrogen 
bonding capability that stabilizes amphiphilic α-helix formation by AMPs upon membrane 
binding, thereby enhancing their membranolytic action and antimicrobial activity 103, 104.  Together, 
these observations could help explain why MH5 appears able to evade some adaptive mechanisms 
of resistance possessed by S. aureus to combat anionic AMPs and how the peptide targets 
membranes of the organism 33, 105. Indeed, it may also be that the stabilisation of MH5 α-helical 
structure by low pH optimises the orientation of these amide groups for targeting and binding S. 
aureus membranes, thereby promoting maximal membranolytic activity of the peptide against this 
organism under pH conditions optimal for its growth. 
Conditions of pH play a variable role in the interactions of AMPs and microbes. One the one 
hand, it can play a role in the protection of these organisms by contributing to the proton motive 
force (PMF) of the CM 106 and thereby power efflux pumps that extrude AMPs 107. Low pH can 
exert a protective effect by promoting the membrane anchoring of cell wall enzymes and thereby 
shield these organisms from AMPs 108, 109. Acid conditions have also been shown to promote 
resistance to AMPs in soil bacteria 92 and to inhibit the antibacterial activity of endogenous human 
peptides, such as defensins and LL-37, to organisms found in lungs 110, 111. On the other hand, PMF 
dependent efflux pumps also appear able to import porcine, bovine and other AMPs, thereby 
promoting their activity 112-114. The promotion of  antimicrobial action by low pH has been reported 
for a number of AMPs, including human hepcidins 115, gads 116 clavanins and styelins 117 from 
marine organisms, and a range of synthetic peptides 118-121, along with the anticancer activity of a 
variety of  AMPs 16. For the most, part, these studies have focussed on cationic AMPs and there 
has been less research into the effects of pH on anionic AMPs 94, 95. It has been reported that acid 
condition promote amyloid formation  by  dermaseptin PD-3-7, which was predicted to be a AMPs 
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storage strategy by the host amphibian 122 and the membrane interactions of the dermcidin 
derivative, DCD-1, which is an α-helical AMP with potent antibacterial activity 123.  In the present 
study, MH5 was found to possess levels of circa 45 % α-helicity at pH 7, which increased to 50 
% α-helicity at pH 6 in the presence of lipid mimics of S. aureus membranes containing 
physiological levels of Lys-PG (Figure 4B). MH5 also partitioned into these lipid mimics in a 
manner that was enhanced by low pH, inducing surface pressure changes of 5.6 mN m-1 at pH 7, 
which increased to 6.2 mN m-1 at pH 6 (Figure 5B). These results clearly suggest that the 
stabilization of α-helical structure is a major driver in the ability of MH5 to insert into S. aureus 
membranes under the low pH conditions that are optimal for the growth of the organism. 
Moreover, surface pressure changes of this order suggest that MH5 inserts primarily into the lipid 
head-group region of these membranes, as reported for other cationic AMPs 104. The presence of 
MH5 led to increases in the lipid packing density of these membrane mimics, which were ten-fold 
greater at pH 6 as compared to the corresponding effects at pH 7, which is consistent with the 
enhanced ability of the peptide to partition into these membranes at low pH (Table 2). The presence 
of MH5 also led to increases in thermodynamic stability of these membrane mimics, which were 
three-fold greater at pH 6 as compared to the corresponding effects at pH 7 (Figure 7). In 
combination, these results suggest that acid conditions facilitated the ability of MH5 to partition 
into membranes of S. aureus via surface associated binding of the peptide that permits the bridging 
of anionic lipid head-groups, thereby stabilizing the structure of the membrane, as recently 
reported for other cationic peptides with activity against the organism 23 and for other tilted 
peptides involved in membrane binding 98.  Most probably, this bridging function is served by the 
two terminal amide groups possessed by MH5 given that these are they are only positively charged 
residues possessed by the peptide and, as suggested above, low pH appears to stabilize MH5 α-
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helical structure thereby optimising the orientation of these amide groups for binding S. aureus 
membranes. Indeed, given that the anionic residues possessed by the peptide form a centrally 
located cluster in relation to the longitudinal axis of α-helical MH5 (Figure 1C), we speculate that 
these residues may complement the bridging function of the peptide by interacting with the head-
groups of Lys-PG.  
Although it is generally accepted that lipid vesicle systems provide good mimics of bacterial 
membranes, the permeabilization of these systems by AMPs shows complex behaviour  90, 91 and 
work on these peptides therefore tends to compare the relative profiles of lysis between AMPs 
rather than with other pharmacological processes 80, 124. Using this approach appeared to show that 
MH5 possessed a strong ability to permeabilise lipid mimics of S. aureus membranes containing 
physiologically relevant levels of Lys-PG, which at the MIC of the peptide (90 µM), were circa 
40  % lysis at pH 7, increasing to around 48  % lysis at pH 6 (Figure 9D). There is the possibility 
that this pH dependent release of calcein from vesicles was related to the physical properties of 
these lipid bodies. For example, heterogeneity in their ability to function as lipid permeability 
barriers may facilitate higher levels of dye release at lower pH or some entrapped calcein could be 
bound to lipid and only released by vesicles at lower pH.  However, correlating with our calcein 
release data (Figure 9), low pH strongly enhanced the ability of MH5 to both adopt membrane 
interactive structure (Figure 4) and penetrate monolayers with the same lipid compositions as our 
vesicle systems (Figure 5). Taken in combination, these results strongly suggest that MH5 has an 
ability to lyse membranes of S. aureus that has a low pH optimum, thereby facilitating killing of 
the organism under the biologically relevant pH conditions that are optimal for its growth.  Based 
on our data, it is difficult to provide a clear picture of the bacteriolytic mechanism used by MH5 
but the acid facilitated ability of the peptide to stabilise membranes of S. aureus (Table 2, Figure 
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7) via head-group partitioning (Figure 5) prior to lytic action (Figure 9) is suggestive of a ‘Carpet’-
like mechanism of membranolysis. Using this mechanism, AMPs ‘carpet’ the target membrane 
surface in a nonspecific manner until a critical peptide concentration is reached when the induction 
of lesions leads to the disruption of lipid packing and bilayer disintegration 14, 125. Indeed, this 
suggestion is further supported by the observation that the lytic action of MH5 (Figures 8 and 9) 
generally showed kinetics that were similar to the Michaelis-Menten-type kinetics of lytic AMPs 
that utilise ‘Carpet’-like mechanisms in their antimicrobial action, typically the amphibian peptide, 
aurein 2.5 74, 76, 80. Based on this similarity in kinetics, we speculate that increasing concentrations 
of MH5 in our membrane systems led to progressively greater numbers of lesions in these 
membranes with the additive effect of these lesions resulting in the maximal levels of 
membranolysis observed for the peptide (Figure 9). The kinetics of the lysis curves representing 
this membranolytic action were differentiated by their characteristic Km values, which provides an 
inverse measure of the affinity of MH5 for our membrane systems and ranged between 38 µM at 
pH 6 to 68 µM at pH 8 (Figure 9). As shown for other AMPs that use the Carpet mechanism, these 
differing lipid affinities would affect the properties of the membrane lesions induced by the 
peptide, such as depth, size and temporal stability 14, 126.  Differences in the properties of these 
lesions would then lead to the differing lytic efficiencies and varying levels of maximal 
membranolysis shown by the peptide for our membrane systems, indicated by their Emax values, 
which ranged between 40  % at pH 8 and 73  % at pH 6  % (Figure 9). These data clearly suggest 
that acid conditions promote the ability of MH5 to kill S. aureus by enhancing the lipid affinity of 
the peptide and thereby its capacity for membranolyic action. Moreover, these data also indicate 
that the lipid affinity of MH5 is much lower than that of cationic AMPs 124 and could help explain 
the relatively high MIC of the peptide (90 µM). It is generally accepted that anionic AMPs have 
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less potent antimicrobial activity than their cationic counterparts and it has been suggested that the 
former peptides arose to complement the action of the latter peptides, in combating microbial 
resistance mechanisms for example 94. It is interesting to note that a number of amphibian AMPs 
appear to kill bacteria via the ‘Carpet’ mechanism 127-130 with tilted structure incorporated into 
their lytic action 68, 73, 131 and the partitioning of peptides via the use of tilted α-helices to anchor 
to the membrane has been observed 98. MH5 showed the potential to form a tilted α-helix (Figure 
1) with compositional and structural similarities to that formed by the HA2 peptide (Figure 1A and 
1B), which is also anionic and exhibits enhanced levels of α-helicity and membrane perturbation 
at low pH 68-70. It may therefore be that the low pH mediated stabilisation of MH5 tilted structure 
promotes the membranolytic activity of the peptide towards S. aureus, which would constitute a 
pH dependent mechanism of antimicrobial action that does not yet appear to have been described 
for AMPs. 
In summary, our data clearly show that S. aureus has developed Lys-PG mediated mechanisms 
of resistance to AMPs that give the organism some protection from the action of maximin H5. The 
peptide is able to overcome these resistance mechanisms, although its MIC is relatively high for 
AMPs, which may reflect the effect of these protective mechanisms. The action of maximin H5 
against S. aureus involves a membranolytic mode of action that is facilitated by the adoption of 
amphiphilic α-helical structure by the peptide and is enhanced by pH conditions that favour the 
growth of the organism. Indeed, it is tempting to speculate that the secretion of MH5 by the host 
toad, B. maxima 7, may have developed specifically to combat the organism, particularly in view 
of the fact that S. aureus appears to be the sole bacterial target of the peptide 7, 9. Taking these 
observations with the generally low levels and manipulability of maximin H5’s  haemolytic 
activity (Figure 10) 7, 8, 102, it would seem that the peptide is worthy of further investigation as a 
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potential template for development as an anti-staphylococcal agent in areas under investigation for 
other AMPs such as surface decontaminants 132, topical anti-infectives 133 and animal husbandry 
agents 134. Indeed, although maximin H5 has no antiviral properties itself, the peptide seems to 
constitute a highly malleable template for the production of derivatives with activity against these 
organisms. Strongly basic derivatives of maximin H5 were found to have potent activity against 
the human immune-deficiency virus 9 whilst isoforms of the peptide with no net charge were found 
to be strongly antiviral when coupled to activated fullerenes, which acted as a novel nanocarrier 
135. Taken with the rapid progress in addressing problems associated with the therapeutic 
development of AMPs, such as proteolytic stability and systemic toxicity 103, it may be that the 
template provided by maximin H5 is able to expand the range of amphibian peptides that are 
already in clinical trials  133, 136, 137.   
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TABLES.  
Table 1. Conformational contributions to the secondary structure of MH5 in the presence of 
membranes formed from S. aureus lipid extracts.  
pH α-helical structure  
                  (%) 
β-strands 
         (%) 
β-turns 
          (%) 
Unordered 
(%) 
6 58 ± 3.1 17 ± 3.1 7 ± 3.1 18 ± 3.1 
7 54 ± 1.0 12 ± 1.0 1 ± 1.0 21± 1.0 
8 47 ± 0.5 25 ± 0.5 8 ± 0.5 21 ± 0.5 
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Table 2: The compressibility modulus, Cs-1 mN m-1, for lipid mimics of S. aureus membranes in 
the presence and absence of MH5 at varying pH.   
 DOPG CL Lys-
DOPG 
DOPG:CL:Lys-DOPG in the molar ratio 55:5:X 
    X = 0 
 
X = 20  X= 40  X = 60 X = 80 
pH 6         
- MH5 70.14 39.23 49.47 33.02 35.78 41.45 46.92 49.71 
+ MH5 99.67 40.15 85.18 69.83 104.91 108.27 109.94 117.08 
pH 7         
- MH5 45.27 28.12 38.11 31.06 32.92 36.07 38.06 45.03 
+ MH5 61.49 43.54 74.92 33.68 36.76 43.54 63.82 74.92 
pH 8         
- MH5 36.60 27.70 26.51 25.24 28.77 30.76 32.69 34.33 
+ MH5 36.43 53.47 47.5 29.02 30.73 32.51 34.92 37.68 
 
Monolayers were formed from either, DOPG, CL, Lys-DOPG or DOPG:CL:Lys-DOPG in the 
molar ratio 55:5:X where X= 0, 20, 40, 60 or 80, as described above. These data show that pH and 
the presence of both Lys-DOPG and MH5 influence the rigidity and lipid-packing characteristics 
of lipid mimics of S. aureus membranes, as discussed in the text. In relation to physiological levels 
of Lys-PG in membranes of S. aureus, in the absence of MH5, the Cs-1 of monolayers were 36.07 
mN m-1 (X = 40) at pH 7 and 42.92 mN m-1 (X = 60) at pH 6, indicating that the latter monolayers 
were more rigid and possessed relatively denser lipid packing than the former monolayers (Table 
II). The presence of MH5 led to increases in the Cs-1 of both these monolayers, which were 43.54 
mN m-1 (X = 40) at pH 7 and 109.94 at mN m-1 (X = 60). These latter results indicate that the 
presence of MH5 increased the rigidity and lipid packing density of both monolayers, which is 
consistent with the peptide partitioning into these membranes. Moreover, this effect was of the 
order of ten-fold greater at pH 6 (change in Cs-1 of 63.02) as compared to pH 7 (change in Cs-1 of 
7.47), indicating that the ability of MH5 to partition into membranes of S. aureus is strongly 
enhanced by the low pH conditions that are optimal for the growth of the organism (Table 2). 
Values of Cs-1 were determined in quadruplicate and the mean value derived, as described above. 
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FIGURE CAPTIONS  
Figure 1. Primary structure analysis of MH5. (A) The peptide was analysed according to 
hydrophobic moment plot methodology, which yielded values of 0.44 and 0.29 for < μH > and < 
H > respectively. Values of < μH > with this order of magnitude are generally indicative of the 
potential to form α-helical structure in an anisotropic environment with activity at an aqueous or 
membrane interface 66. Using < μH > and < H >, MH5 was plotted on the extended hydrophobic 
moment plot diagram 53 and yielded a data point in the area indicating the potential to form a tilted 
peptide (blue area) with similar parameters to HA2, a known tilted peptide (Figure 1A). HA2 and 
other tilted peptides possess a hydrophobicity gradient along the α-helical long axis, which causes 
the α-helix to penetrate membranes at a shallow angle thereby disturbing membrane lipid 
organisation and compromising bilayer integrity 14, 67-71. (B) To characterise the potential tilted 
peptide formed by MH5, amphiphilic profiling analysis was undertaken, which essentially 
visualises potential hydrophobicity gradients via plots of - < µH >  along a peptide’s sequence 72. 
This analysis revealed that MH5 possessed a strong hydrophobicity gradient, which decreased in 
the direction of the N terminus to the C terminus and extended over most of the peptide’s primary 
structure (Figure 1B). (C) MH5 was represented as a two-dimensional axial projection, assuming 
a residue periodicity of 100° 54, and showed well defined amphiphilicity (Figure 1C). Consistent 
with the ability to form a tilted peptide, this α-helix possesses a wide apolar face, which is 
predominantly formed from strongly hydrophobic residues such as leucine, isoleucine and valine. 
The α-helix possesses a narrower polar face, which includes multiple glycine residues and is 
strongly anionic due the presence of a triplet of aspartic acid residues. These residues, D11, D14 
and D15 (shown in blue), essentially define the polar face of the MH5 α-helix and are centrally 
clustered in relation to the long axis of this α-helix. The long axis of the α-helix is demarked at the 
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C-terminus and N-terminus, respectively, by the residues I1 and L20, which each carry an amide 
moiety (Figure 1C). Also shown in Figure 1C is a two-dimensional axial projection of the HA2 
peptide, which forms a α-helix with structural similarities to that of MH5, including a wide apolar 
face formed from strongly hydrophobic residues and a narrower polar face, which possesses 
multiple glycine residues and is strongly anionic due the presence of glutamic acid and aspartic 
acid residues (E11, E15 and D19, shown in blue) (Figure 1C). 
Figure 2. The surface activity of MH5.  (A) MH5 was investigated for activity at an air / buffer 
interface at pH 6 (dotted grey), pH 7 (black) and pH 8 (grey).  Across this pH range, the surface 
activity of the peptide was very similar, increasing rapidly up to MH5 concentrations of 2 µM and 
inducing maximal surface pressure changes of circa 28 mN m-1. At MH5 concentrations above 2 
µM, the surface pressure of these peptide monolayers became independent of MH5 concentration, 
indicating that air / buffer interface was saturated with molecules of the peptide. (B) The 
orientation of MH5 at an air / buffer interface was investigated using compression isotherms at pH 
6 (dotted grey), pH 7 (black) and pH 8 (grey), which had a generally sigmoidal shape indicative 
that MH5 forms stable monolayers 18, 22. Across this pH range, these monolayers showed collapse 
surface pressures ranging between 26.8 and 24.1 mN m-1, indicating the presence of well-ordered 
peptide films. The corresponding surface areas per molecule of MH5 ranged from 1.9 to 1.6 nm2, 
which is consistent with the peptide in an α-helical conformation, orientated perpendicular to the 
interface 77.  The extrapolated areas at п = 0 mN m-1 for these isotherms ranged between 4.5 and 
4.1 nm2 at pH 6, 7 and 8, consistent with the peptide in an α-helical conformation orientated 
parallel to the air / buffer interface 79. In all cases, experiments were performed at room temperature 
(20 ⁰C), repeated in quadruplicate and the mean value taken. 
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Figure 3. The secondary structure of MH5 in the presence of membranes formed from S. 
aureus lipid extracts. SUVs were formed from lipid extracts of S. aureus, as described above, and 
CD analysis used to determine the secondary structure of MH5 in the presence of these lipid bodies 
at pH 6 (dotted grey), pH 7 (black) and pH 8 (grey).  The resulting CD spectra showed minima at 
221 - 222 and 209 – 210 nm, which is indicative of α-helical structure in MH5 (Table 1). The 
levels of this structure were around 48 % at pH 8, which increased by around 10 % as pH was 
decreased to pH 6, clearly showing that the ability of MH5 to adopt α-helical structure is enhanced 
by low pH (Table 1). In all cases, CD experiments were conducted at 20 ⁰C, performed in 
quadruplicate and the mean value derived. 
Figure 4. SUVs were formed from lipids and lipid mixtures, as described above, and CD analysis 
used to determine the secondary structure of MH5 in the presence of these lipid bodies across a 
range of pH. In all cases, the resulting CD spectra showed minima at 221 - 222 and 209 – 210 nm, 
indicative of α-helical structure in MH5.  (A) shows typical examples of these spectra for MH5 at 
pH 7 and in the presence of DOPG (Red), CL (blue), LysylPG (green) and  DOPG:CL:LysylPG 
in the molar ratio 55:5:X where X =  10 (purple), 20 (dotted dark grey), 30 (dotted orange), 40 
(dashed light blue), 50 (dashed black), 60 (dashed light grey) and 70 (dotted dark blue). (B) shows 
levels of α-helical structure in MH5, which were determined as described above, for pH 6 (black 
crosses), 7 (dark grey crosses) and 8 (light grey crosses), in the presence of DOPG:CL:LysylPG 
in the molar ratio 55:5:X where X =  20, 40, 60, 80 or 100. At each pH studied, MH5 was 
predominantly α-helical and possessed similar levels of this structure for all values of X. However, 
for a given level of X, a statistically significant difference in levels of MH5 α-helicity was observed 
as pH was varied (Figure 4B), decreasing from circa 50 % at pH 6 to circa 40 % at pH 8 [F = 
98.376; p = 0.001]. In relation to physiological levels of LysPG in membranes of S. aureus, MH5 
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possessed levels of α-helicity of circa 45 % at pH 7 (X = 40), which increased to 50 % at pH 6 (X 
= 60). In all cases, CD experiments were conducted at 20 ˚C, performed in quadruplicate and the 
mean value derived. Error bars represent standard deviations. 
Figure 5. The interactions of MH5 with lipid mimics of S. aureus membranes. Lipid 
monolayers mimetic of S. aureus membranes were constructed, as described above, and the 
interaction of MH5 with these monolayers at constant area investigated. (A) shows the time course 
for interactions of the peptide with monolayers derived from lipid extracts of S. aureus membranes 
at pH 6 (black), pH 7 (dark grey) and pH 8 (light grey). At pH 7 and pH 8, MH5 partitioned into 
these monolayers, inducing maximal surface pressure changes of circa 4.0 mN m-1 to 3.5 mN m-1 
over 400 secs. However, at pH 6, MH5 induced maximal surface pressures in monolayers of the 
order of 8.0 mN m-1 over 120 secs, clearly showing that the ability of the peptide to partition into 
lipid mimics of S. aureus membranes monolayers was enhanced by low pH (Figure 5A). (B) shows 
the interaction of MH5 with monolayers formed from DOPG:CL:Lys-DOPG in the molar ratio 
55:5:X where X =  0 , 20, 40, 60, 80 or 100, at pH 6 (black crosses), 7 (dark grey crosses) and 8 
(light grey crosses). For each pH studied, regression analysis indicated a strong negative 
correlation between X and the maximal pressure change induced by MH5 (R2 = 0.97). These 
results show that the ability of MH5 to partition into these lipid mimics of S. aureus membranes 
is influenced by their Lys-PG content and pH, as discussed in the text. In relation to physiological 
levels of Lys-PG in membranes of S. aureus, MH5 induced maximal surface pressure changes of 
5.6 mN m-1 at pH 7 (X = 40), which increased to 6.2 mN m-1 at pH 6 (X = 60) (Figure 5B). These 
results indicate that the ability of the peptide to partition into S. aureus membranes is enhanced by 
the low pH conditions that are optimal for the growth of the organism. Monolayer experiments 
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were performed in quadruplicate and the mean value derived, as described above. Error bars 
represent standard deviations. 
Figure 6. Compression isotherm analysis of MH5 interactions with lipid mimics of S. aureus 
membranes. Lipid monolayers were constructed and compressed in the presence and absence of 
MH5 at varying pH, as described above, to produce isotherms, which are denoted as follows: 
DOPG (solid black), CL (solid dark grey), Lys-DOPG (solid light grey), and DOPG:CL:Lys-
DOPG in the molar ratio 55:5:X where X =  0 (black dotted dash), 20 (dark grey dotted), 40 (light 
grey dotted), 60 (dark grey dotted dash) or 80 (black dotted). Each measurement was performed 
in quadruplicate and the mean value derived, as described above. These isotherms were then used 
to derive values for Cs-1, the compressibility modulus (Table 2), and ∆Gmix, the Gibbs free energy 
of mixing (Figure 7), of these experimental systems. 
Figure 7. The Gibbs free energy of mixing for lipid mimics of S. aureus membranes. 
Compression isotherms were derived, as described above (Figure 6) and used to derive values for 
the Gibbs free energy of mixing, ∆Gmix, at 20 mN m-1 for monolayers formed from DOPG:CL:Lys-
DOPG in the molar ratio 55:5:X where X = 0 (black), 20 (dark grey), 40 (grey), 60 (white) or 80 
(light grey) in the absence (solid) and presence (diagonals) of MH5. These data show that pH and 
the presence of both Lys-DOPG and MH5 influence the thermodynamic stability of lipid mimics 
of S. aureus membranes, as discussed in the text. In relation to physiological levels of Lys-PG in 
membranes of S. aureus, in the absence of MH5, the ∆Gmix of monolayers were -2.0 (X = 40) at 
pH 7 and -5.0 (X = 60) at pH 6, indicating that the latter monolayers were thermodynamically 
more stable than the former monolayers. The presence of MH5 led to increases in the ∆Gmix values 
of both these monolayers, which were -3.0 (X = 40) at pH 7 and -8.0 (X = 60). These latter results 
indicate that the presence of MH5 increased the thermodynamic stability of both monolayers and 
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that this effect was of the order of three-fold greater at pH 6 (change in ∆Gmix of -1) as compared 
to pH 7 (change in ∆Gmix of -3). These results show that the ability of MH5 to increase the 
thermodynamic stability of membranes of S. aureus is strongly enhanced by low pH conditions 
that are optimal for the growth of the organism. Values of ∆Gmix were determined in quadruplicate 
and the mean value derived, as described above. Error bars represent standard deviations. 
Figure 8. The lysis of vesicles formed from lipid extracts of S. aureus membranes by MH5. 
Calcein was entrapped in vesicles formed from S. aureus membrane lipids and the levels of the 
dye released by MH5 used to calculate the  % lysis induced by the peptide at pH 6 (black crosses), 
pH 7 (dark grey crosses) and pH 8 (light grey crosses). At each pH studied, the peptide induced 
the release of calcein from these vesicles with the level of the dye released increasing as the 
concentration of MH5 became progressively higher, showing that MH5 was generally 
membranolytic to these membranes. At MH5 concentrations of circa 500 μM, the release of 
calcein from these vesicles became independent of peptide concentration, indicating that 
membranes were saturated with MH5 and levels of dye release were maximal, ranging from 40.3 
% at pH 8 to 72.6 % at pH 6. It was also found that the levels of lysis induced by the peptide were 
enhanced by increasing pH, for example, at the MIC of MH5 for S. aureus, levels of dye release 
induced by the peptide were circa 30 % at pH 8 but rose to 57 % at pH 6. Values of the  % lysis 
were determined in quadruplicate and the mean value derived, as described above.  
 
Figure 9. The lysis of vesicles formed from mixtures of PG, CL and Lys-DOPG by MH5. 
Calcein was entrapped in vesicles formed DOPG:CL:Lys-DOPG in the molar ratio 55:5:X where 
X =  0, 20, 40, 60 and 80 and 100, and the levels of the dye released by MH5 used to calculate the  
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% lysis induced by the peptide at  pH 6 (Figure 9A), pH 7 (Figure 9B) and pH 8 (Figure 9C) for 
X = 0 (black cross), X = 20 (dark grey cross), X = 40 (black dotted circles), X = 60 (light grey 
dotted circles), X = 80 (dark grey dotted circles) or X = 100 (light grey crosses). These plots show 
that the membranolytic action of MH5 generally exhibited kinetics that were similar to the 
Michaelis-Menten-type kinetics of lytic AMPs that utilise ‘Carpet’-like mechanisms in their 
antimicrobial action 74, 76, 80.  These kinetics were characterized by Km values, which provides an 
inverse measure of the lipid affinity of the peptide, along with Emax values, which represent the 
lytic efficiency of MH5. It was found that maximal levels of lysis and the lipid affinity of the 
peptide for a given Lys-DOPG concentration were highest at pH 6 and generally decreased with 
increasing pH. For example, at X = 20 and an MH5 concentration of 250 µM, the maximal levels 
of calcein released by the peptide, Emax, increased from circa 58.0  % at pH 8 to 73.0  % at pH 6 
(Figures 9A, 9b and 9C).  For the same lytic curve, Km decreased from 45 μM at pH 8 to 38 μM at 
pH 6, indicating an increase in the lipid affinity of the peptide (Figures 9A and 9C). In addition to 
pH, these results also show that the concentration of MH5 and the presence of Lys-DOPG 
influence the ability of MH5 to lyse lipid mimics of S. aureus membranes, as discussed in the text. 
Figure 9D, which was derived from Figures 9A, 9B and 9C, shows the  % lysis induced by MH5 
at its MIC of 90 µM in vesicles formed DOPG:CL:Lys-DOPG in the molar ratio 55:5:X  with 
varying X at pH 6 (black crosses), pH 7 (dark grey crosses) and pH 8 (light grey crosses). At the 
physiological levels of Lys-PG found in membranes of S. aureus, MH5 induced levels of lysis of 
circa 40 % (X = 40) at pH 7, which rose to 48 % (X = 60) at pH 6, indicating that the ability of the 
peptide to lyse membranes of the organism is strongly enhanced by the low pH conditions that are 
optimal for its growth (Figure 9D). In all cases, values of the % lysis were determined in 
quadruplicate and the mean value derived, as described above.  
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Figure 10. The haemolytic properties of MH5. Washed ovine erythrocytes were incubated with 
MH5 and the % lysis of these erythrocytes monitored by the absorbance of haemoglobin release 
at pH 6 (blue), pH 7 (red) and pH 8 (green). In each case, the peptide showed similar kinetics with 
haemolysis increasing up to MH5 concentrations of circa 1000 μM and then becoming 
independent of peptide concentration. Levels of haemolysis were generally very low (> 2 %) and 
increased with decreasing pH. At the MIC of MH5, the % lysis induced by the peptide varied 
between 1.6 % at pH 6 and 1.2 % at pH 8.  Values of the % haemolysis were determined in 
quadruplicate and the mean value derived, as described above.  
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